Skip to main content
. 2013 Feb;34(2):354–359. doi: 10.3174/ajnr.A3202

Fig 1.

Fig 1.

Rates of favorable outcome of endovascularly treated patients in groups based on total procedure time in comparison with rates observed in placebo-treated PROACT II patients.